Prenetics is the pioneer of genetic testing in the south-east Asian region. They provide important health-related information to their clients. By collecting saliva samples from the clients, they can analyze their genetic makeup and tell the clients their response to certain drugs or their diet or their risk of having cancer. Their clients can take reference from the information and adjust their diet and habits to improve their health in the future.
| Company Name | Prenetics Limited |
| Brand Name | Prenetics |
| Industries | BioTech Healthcare |
| Year of Establishment | 2014 |
| Founder(s) | Danny Yeung Lawrence Tzang Prof. Michael M Yang |
| No. of Employees | 51-100 |
| Regional Coverage | Hong Kong Malaysia Philippines Singapore South Africa Taiwan Thailand United Kingdom Vietnam |
| Clients | / |
| Stage | Series B |
| Investor(s) | REAPRA Venturra Capital Egarden Ventres M Fund VC Ping An Ventures Beyond Ventures Venturra Capital Yuantai Investment Partners |
| Raising Fund | Yes |
| Pre-money valuation | / |
| Post-money Valuation | / |
| Fundraising target | 40M USD (Nov 2017) |
| Fundraising History | 40M USD (Oct 2017) 10M USD (Mar 2016) 2.7M USD (Dec 2014) |
| Media Explosure | 11-20 |
| Company Email | [email protected] |
[dcb id=5586]